These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
762 related articles for article (PubMed ID: 9653017)
21. Changes in expression of P2X7 receptors in NOD mouse pancreas during the development of diabetes. Coutinho-Silva R; Robson T; Beales PE; Burnstock G Autoimmunity; 2007 Mar; 40(2):108-16. PubMed ID: 17364502 [TBL] [Abstract][Full Text] [Related]
22. Systemic treatment with sympatholytic dopamine agonists improves aberrant beta-cell hyperplasia and GLUT2, glucokinase, and insulin immunoreactive levels in ob/ob mice. Jetton TL; Liang Y; Cincotta AH Metabolism; 2001 Nov; 50(11):1377-84. PubMed ID: 11699060 [TBL] [Abstract][Full Text] [Related]
23. Apoptosis and beta-cell destruction in pancreatic islets of NOD mice with spontaneous and cyclophosphamide-accelerated diabetes. Augstein P; Elefanty AG; Allison J; Harrison LC Diabetologia; 1998 Nov; 41(11):1381-8. PubMed ID: 9833948 [TBL] [Abstract][Full Text] [Related]
24. Effects of insulin like growth factor-1 and insulin on effector T cells generating autoimmune diabetes. Bergerot I; Fabien N; Thivolet C Diabetes Metab; 1996 Jul; 22(4):235-9. PubMed ID: 8767168 [TBL] [Abstract][Full Text] [Related]
25. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse. Gallichan WS; Balasa B; Davies JD; Sarvetnick N J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077 [TBL] [Abstract][Full Text] [Related]
26. Nicotinamide prevents the development of diabetes in the cyclophosphamide-induced NOD mouse model by reducing beta-cell apoptosis. O'Brien BA; Harmon BV; Cameron DP; Allan DJ J Pathol; 2000 May; 191(1):86-92. PubMed ID: 10767724 [TBL] [Abstract][Full Text] [Related]
27. IL-4 expression at the onset of islet inflammation predicts nondestructive insulitis in nonobese diabetic mice. Fox CJ; Danska JS J Immunol; 1997 Mar; 158(5):2414-24. PubMed ID: 9036992 [TBL] [Abstract][Full Text] [Related]
28. GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice. Wang Z; Gleichmann H Diabetes; 1998 Jan; 47(1):50-6. PubMed ID: 9421374 [TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical demonstration of nitrotyrosine, a biomarker of oxidative stress, in islet cells of the NOD mouse. Reddy S; Bradley J Ann N Y Acad Sci; 2004 Dec; 1037():199-202. PubMed ID: 15699517 [TBL] [Abstract][Full Text] [Related]
30. Oral administration of insulin to female nonobese diabetic mice inhibited diabetes and induced Fas ligand expression on islets of Langerhans. Wang H; Li Y; Sun Q; Yang G Chin Med J (Engl); 2000 May; 113(5):433-6. PubMed ID: 11776099 [TBL] [Abstract][Full Text] [Related]
31. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice. Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666 [TBL] [Abstract][Full Text] [Related]
32. Streptozotocin-induced pancreatic insulitis in mice. Morphologic and physiologic studies. Like AA; Appel MC; Williams RM; Rossini AA Lab Invest; 1978 Apr; 38(4):470-86. PubMed ID: 205725 [TBL] [Abstract][Full Text] [Related]
33. NO-mediated cytotoxicity contributes to multiple low-dose streptozotocin-induced diabetes but not to NOD diabetes. Yasuda H; Jin Z; Nakayama M; Yamada K; Kishi M; Okumachi Y; Arai T; Moriyama H; Yokono K; Nagata M Diabetes Res Clin Pract; 2009 Feb; 83(2):200-7. PubMed ID: 19117633 [TBL] [Abstract][Full Text] [Related]
34. [Autoimmunity and insulin-dependent diabetes mellitus. Experimental data and therapeutic prospects]. Thivolet C; Khallouf E Pediatrie; 1989; 44(4):247-57. PubMed ID: 2677968 [TBL] [Abstract][Full Text] [Related]
35. Insulin-induced immunohistochemical and morphological changes in pancreatic beta-cells of streptozotocin-treated diabetic rats. Adewole SO; Ojewole JA Methods Find Exp Clin Pharmacol; 2007 Sep; 29(7):447-55. PubMed ID: 17982509 [TBL] [Abstract][Full Text] [Related]
36. Expression and immune response to islet antigens following treatment with low doses of streptozotocin in H-2d mice. Herold KC; Baumann E; Vezys V; Buckingham F J Autoimmun; 1997 Feb; 10(1):17-25. PubMed ID: 9080296 [TBL] [Abstract][Full Text] [Related]
37. Immunolocalization of monocyte chemoattractant protein-1 in islets of NOD mice during cyclophosphamide administration. Reddy S; Bai Y; Robinson E; Ross J Ann N Y Acad Sci; 2006 Oct; 1079():103-8. PubMed ID: 17130538 [TBL] [Abstract][Full Text] [Related]
38. Prevention of diabetes in the nonobese diabetic mouse by oral immunological treatments. Comparative efficiency of human insulin and two bacterial antigens, lipopolysacharide from Escherichia coli and glycoprotein extract from Klebsiella pneumoniae. Saï P; Rivereau AS Diabetes Metab; 1996 Oct; 22(5):341-8. PubMed ID: 8896996 [TBL] [Abstract][Full Text] [Related]